These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24772046)

  • 21. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.
    Loftus EV
    Gastroenterology; 2004 May; 126(6):1504-17. PubMed ID: 15168363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the epidemiology of inflammatory bowel diseases].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Feb; 148(5):223-8. PubMed ID: 17344143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case-control study.
    Hlavaty T; Toth J; Koller T; Krajcovicova A; Oravcova S; Zelinkova Z; Huorka M
    United European Gastroenterol J; 2013 Apr; 1(2):109-19. PubMed ID: 24917948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand.
    Han DY; Fraser AG; Dryland P; Ferguson LR
    Mutat Res; 2010 Aug; 690(1-2):116-22. PubMed ID: 19751746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental risk factors in inflammatory bowel disease.
    Koutroubakis I; Manousos ON; Meuwissen SG; Pena AS
    Hepatogastroenterology; 1996; 43(8):381-93. PubMed ID: 8714231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology and risk factors of inflammatory bowel disease.
    Ye Y; Pang Z; Chen W; Ju S; Zhou C
    Int J Clin Exp Med; 2015; 8(12):22529-42. PubMed ID: 26885239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007.
    Vahedi H; Merat S; Momtahen S; Olfati G; Kazzazi AS; Tabrizian T; Rashtak S; Khaleghnejad R; Khademi H; Malekzadeh F; Nasseri-Moghaddam S; Malekzadeh R
    Arch Iran Med; 2009 Sep; 12(5):454-60. PubMed ID: 19722766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of environmental factors on the onset and course of inflammatory bowel disease.
    Dutta AK; Chacko A
    World J Gastroenterol; 2016 Jan; 22(3):1088-100. PubMed ID: 26811649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Lytras T; Bonovas S
    Gastroenterology; 2019 Sep; 157(3):647-659.e4. PubMed ID: 31014995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect.
    Parkes GC; Whelan K; Lindsay JO
    J Crohns Colitis; 2014 Aug; 8(8):717-25. PubMed ID: 24636140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of inflammatory bowel disease.
    Whelan G
    Med Clin North Am; 1990 Jan; 74(1):1-12. PubMed ID: 2404170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study.
    Preda CM; Manuc T; Istratescu D; Louis E; Baicus C; Sandra I; Diculescu M; Reenaers C; van Kemseke C; Nitescu M; Tieranu C; Sandu CG; Oprea-Calin G; Tugui L; Viziru S; Ciora CA; Gheorghe LS; Manuc M
    Maedica (Bucur); 2019 Sep; 14(3):233-239. PubMed ID: 31798738
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenesis and therapeutic aspects of Crohn's disease.
    Selby W
    Vet Microbiol; 2000 Dec; 77(3-4):505-11. PubMed ID: 11118735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Overview of diet-related study in Crohn's disease].
    Li G; Ren J; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Dec; 18(12):1288-92. PubMed ID: 26704014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crohn's disease: a role of gut microbiota and Nod2 gene polymorphisms in disease pathogenesis.
    Hrnčířová L; Krejsek J; Šplíchal I; Hrnčíř T
    Acta Medica (Hradec Kralove); 2014; 57(3):89-96. PubMed ID: 25649363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing first relapse in patients with Crohn's disease.
    Wright JP
    J Clin Gastroenterol; 1992 Jul; 15(1):12-6. PubMed ID: 1500656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology.
    Timmer A
    Dig Dis; 2003; 21(2):91-104. PubMed ID: 14571108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Potential Role of
    Schultz BM; Paduro CA; Salazar GA; Salazar-Echegarai FJ; Sebastián VP; Riedel CA; Kalergis AM; Alvarez-Lobos M; Bueno SM
    Front Immunol; 2017; 8():191. PubMed ID: 28293241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study.
    Duggan AE; Usmani I; Neal KR; Logan RF
    Gut; 1998 Oct; 43(4):494-8. PubMed ID: 9824576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease related innate immunity and adaptive immunity.
    Huang Y; Chen Z
    Am J Transl Res; 2016; 8(6):2490-7. PubMed ID: 27398134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.